Results 71 to 80 of about 10,865 (205)
Background: Etomidate drug is commonly used for procedural sedation in the emergency department (ED). The incidence rate of etomidate-induced myoclonus is 33%.
Ashly Alexander Fernandez, Neethu C M
doaj +1 more source
Safer prehospital anaesthesia: updated guidelines from the Association of Anaesthetists
Summary Introduction Prehospital emergency anaesthesia is recognised as a high‐risk clinical intervention. These updated guidelines consider changes in prehospital practice and parallel changes in the practice of in‐hospital emergency anaesthesia, with the aim of encouraging standardised safe anaesthetic practice in a challenging clinical area.
David Lockey +9 more
wiley +1 more source
ETOMIDATE IN STATUS EPILEPTICUS
ETOMIDATE IN STATUS ...
PM YEOMAN (15916751) +3 more
core +1 more source
Modified electroconvulsive therapy is a highly effective treatment for various disorders. Its effectiveness depends both on stimulus parameters and anesthetic agent.
Neelofer Jan +6 more
doaj +1 more source
Background and Purpose Long‐lasting cognitive deficits after surgery in aged individuals, referred to as perioperative neurocognitive disorder (NCD), are a significant public health concern. Such postoperative cognitive deficits are dependent on the presence of microglia in the brain, which, when activated, trigger neuroinflammation.
Jinrui Lyu +9 more
wiley +1 more source
The γ-aminobutyric acid type A receptor (GABAAR) is a target for general anesthetics of diverse chemical structures, which act as positive allosteric modulators at clinical doses.
Selwyn S. Jayakar (2119426) +5 more
core +1 more source
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon +3 more
wiley +1 more source
The novel etomidate analog: A potential induction agent
Etomidate is the agent of choice for the induction of anesthesia in patients with cardiovascular illness, hypotension, or shock. Notwithstanding its numerous attributes, etomidate’s most notable adverse impact is adrenocortical suppression.
Konica Chittoria, Ankur Sharma
doaj +1 more source
Pretreatment with Esketamine Reduces Etomidate-Induced Myoclonus During the Induction of Anesthesia: A Randomized Controlled Trial [PDF]
Jiang Wang, Mengmeng Zhu, Yuanyuan Cao, Lei Zhang, Lijian Chen Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People’s Republic of ChinaCorrespondence: Lijian Chen, Department of Anesthesiology ...
Zhu M, Cao Y, Chen L, Zhang L, Wang J
core
Background: A variety of anesthetics including methohexital, thiopental sodium, propofol, ketamine, and etomidate are used for electroconvulsive therapy (ECT), each accompanied by adverse effects that can cause unpleasant experiences for patients ...
Nazemroaya, Behzad +1 more
core +1 more source

